APA (7th ed.) Citation

RAGNI, M. V., JANKOWITZ, R. C., CHAPMAN, H. L., MERRICKS, E. P., KLOOS, M. T., DILLOW, A. M., & NICHOLS, T. C. (2008). A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand disease. Haemophilia : the official journal of the World Federation of Hemophilia, 14(5), 968-977. https://doi.org/10.1111/j.1365-2516.2008.01827.x

Chicago Style (17th ed.) Citation

RAGNI, M. V., R. C. JANKOWITZ, H. L. CHAPMAN, E. P. MERRICKS, M. T. KLOOS, A. M. DILLOW, and T. C. NICHOLS. "A Phase II Prospective Open-label Escalating Dose Trial of Recombinant Interleukin-11 in Mild Von Willebrand Disease." Haemophilia : The Official Journal of the World Federation of Hemophilia 14, no. 5 (2008): 968-977. https://doi.org/10.1111/j.1365-2516.2008.01827.x.

MLA (9th ed.) Citation

RAGNI, M. V., et al. "A Phase II Prospective Open-label Escalating Dose Trial of Recombinant Interleukin-11 in Mild Von Willebrand Disease." Haemophilia : The Official Journal of the World Federation of Hemophilia, vol. 14, no. 5, 2008, pp. 968-977, https://doi.org/10.1111/j.1365-2516.2008.01827.x.